Hong Kong stocks fluctuated | Innovative drug concept defied the market to rise, Trump threatened to impose high tariffs on imported drugs, institutions said the short-term impact may be limited.

According to the Securities Times APP, the concept of innovative drugs rose against the market, as of press time, BeiGene Biotech (06955.HK) rose 11.67% to HK$14.18; Hutchison Medicine (01276.HK) rose 8.72% to HK$65.45; Leaf Pharmaceuticals (02186.HK) rose 7.55% to HK$3.56; China Biopharmaceuticals (01177) rose 4.1% to HK$5.59.